| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Rachel E. Haurwitz | President and CEO | 2025-03-14 | 20,000 | $1.02 | $20.40kBuy |
| Steven Kanner | Chief Scientific Officer | 2025-02-21 | 3,564 | $1.35 | $4.81kSell |
| Ruhi Ahmad Khan | Chief Business Officer | 2025-02-21 | 3,564 | $1.35 | $4.81kSell |
| Barbara G. McClung | Chief Legal Officer | 2025-02-21 | 3,564 | $1.35 | $4.81kSell |
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Pfizer Inc | 5.02% | 4,690,431 | $6.85M | Institution |
| Vanguard Group Inc | 4.52% | 4,226,926 | $6.17M | Institution |
| Rachel E. Haurwitz | 3.92% | 3,664,845 | $5.35M | Insider |
| Fmr LLC | 3.56% | 3,323,284 | $4.85M | Insider |
| Millennium Management LLC | 3.44% | 3,216,535 | $4.70M | Institution |
| Kynam Capital Management LP | 3.28% | 3,067,774 | $4.48M | Institution |
| Blackrock Inc | 1.56% | 1,459,320 | $2.13M | Institution |
| Aberdeen Group PLC | 1.49% | 1,388,905 | $2.03M | Institution |
| Pfm Health Sciences LP | 1.45% | 1,358,831 | $1.98M | Institution |
| Two Sigma Advisers LP | 1.31% | 1,227,400 | $1.79M | Institution |